Colchicine Pill
Sponsors
NYU Langone Health, Bakulev Scientific Center of Cardiovascular Surgery, Universidad Nacional de Colombia, Population Health Research Institute, Sohag University
Conditions
Acute Coronary SyndromeAcute MyocarditisAtrial Fibrillation New OnsetCOVID-19CPPD - Calcium Pyrophosphate Deposition DiseaseColchicineColchicine Adverse ReactionIntracranial Hemorrhages
Phase 2
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
CompletedNCT04359095
Start: 2020-08-18End: 2021-06-30Updated: 2021-08-12
Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage
CompletedNCT05159219
Start: 2022-08-04End: 2024-12-03Updated: 2025-01-16
Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment
Not yet recruitingNCT06855433
Start: 2026-04-10End: 2029-10-01Target: 150Updated: 2025-11-04
Phase 3
Phase 4
Unknown Phase
CLEAR SYNERGY Neutrophil Substudy
CompletedNCT03874338
Start: 2019-03-04End: 2024-08-09Updated: 2024-09-19
Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention
NCT05745818
Start: 2023-03-01End: 2025-03-01Target: 300Updated: 2023-02-27
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
RecruitingNCT06215989
Start: 2024-09-02End: 2028-06-30Target: 6574Updated: 2024-10-30